4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-6-methyl-3-oxo-N-(2-phenylethyl)-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
Chemical Structure Depiction of
4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-6-methyl-3-oxo-N-(2-phenylethyl)-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-6-methyl-3-oxo-N-(2-phenylethyl)-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
Compound characteristics
Compound ID: | L310-3255 |
Compound Name: | 4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-6-methyl-3-oxo-N-(2-phenylethyl)-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide |
Molecular Weight: | 482.56 |
Molecular Formula: | C24 H26 N4 O5 S |
Smiles: | Cc1cc2c(cc1S(NCCc1ccccc1)(=O)=O)OCC(N2Cc1nc(C2CCC2)on1)=O |
Stereo: | ACHIRAL |
logP: | 3.2829 |
logD: | 3.2828 |
logSw: | -3.5721 |
Hydrogen bond acceptors count: | 11 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 98.859 |
InChI Key: | QHQJBJIZCOQYGK-UHFFFAOYSA-N |